SC 13G/A

VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G/A

Company: Apellis Pharmaceuticals, Inc.
Filed: February 14, 2019
Accession Number: 0001072613-19-000089

View Document ↗ View on SEC.gov ↗